182 related articles for article (PubMed ID: 24648485)
1. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
Isakova-Sivak I; Chen LM; Bourgeois M; Matsuoka Y; Voeten JT; Heldens JG; van den Bosch H; Klimov A; Rudenko L; Cox NJ; Donis RO
Clin Vaccine Immunol; 2014 May; 21(5):722-31. PubMed ID: 24648485
[TBL] [Abstract][Full Text] [Related]
2. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
[TBL] [Abstract][Full Text] [Related]
3. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
4. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
5. Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
Isakova-Sivak I; de Jonge J; Smolonogina T; Rekstin A; van Amerongen G; van Dijken H; Mouthaan J; Roholl P; Kuznetsova V; Doroshenko E; Tsvetnitsky V; Rudenko L
PLoS One; 2014; 9(7):e102339. PubMed ID: 25058039
[TBL] [Abstract][Full Text] [Related]
6. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
Dong J; Matsuoka Y; Maines TR; Swayne DE; O'Neill E; Davis CT; Van-Hoven N; Balish A; Yu HJ; Katz JM; Klimov A; Cox N; Li DX; Wang Y; Guo YJ; Yang WZ; Donis RO; Shu YL
Influenza Other Respir Viruses; 2009 Nov; 3(6):287-95. PubMed ID: 19903211
[TBL] [Abstract][Full Text] [Related]
7. Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses.
Nang NT; Song BM; Kang YM; Kim HM; Kim HS; Seo SH
Influenza Other Respir Viruses; 2013 Mar; 7(2):120-31. PubMed ID: 22487301
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.
Chen GL; Lamirande EW; Cheng X; Torres-Velez F; Orandle M; Jin H; Kemble G; Subbarao K
J Virol; 2014 Mar; 88(5):2867-76. PubMed ID: 24371061
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models.
Song MS; Moon HJ; Kwon HI; Pascua PN; Lee JH; Baek YH; Woo GJ; Choi J; Lee S; Yoo H; Oh I; Yoon Y; Rho JB; Sung MH; Hong SP; Kim CJ; Choi YK
J Microbiol; 2012 Jun; 50(3):478-88. PubMed ID: 22752912
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
Fan S; Gao Y; Shinya K; Li CK; Li Y; Shi J; Jiang Y; Suo Y; Tong T; Zhong G; Song J; Zhang Y; Tian G; Guan Y; Xu XN; Bu Z; Kawaoka Y; Chen H
PLoS Pathog; 2009 May; 5(5):e1000409. PubMed ID: 19412338
[TBL] [Abstract][Full Text] [Related]
11. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
12. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
Rudenko L; Desheva J; Korovkin S; Mironov A; Rekstin A; Grigorieva E; Donina S; Gambaryan A; Katlinsky A
Influenza Other Respir Viruses; 2008 Nov; 2(6):203-9. PubMed ID: 19453396
[TBL] [Abstract][Full Text] [Related]
14. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
[TBL] [Abstract][Full Text] [Related]
15. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
[TBL] [Abstract][Full Text] [Related]
16. [Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection].
Sergeeva MV; Kuznetsov VV; Kas'ianenko MA; Shaldzhian AA; Repko IA; Potapchuk MV; Romanova IuR; Tsybalova LM
Vopr Virusol; 2013; 58(6):36-9. PubMed ID: 24772645
[TBL] [Abstract][Full Text] [Related]
17. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.
Lee DH; Park JK; Kwon JH; Yuk SS; Erdene-Ochir TO; Jang YH; Seong BL; Lee JB; Park SY; Choi IS; Song CS
PLoS One; 2013; 8(3):e58186. PubMed ID: 23469269
[TBL] [Abstract][Full Text] [Related]
19. [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
Desheva IuA; Lu Kh; Rekstin AR; Kats DM; Rudenko LG; Klimov AI
Vopr Virusol; 2007; 52(4):27-30. PubMed ID: 17722607
[TBL] [Abstract][Full Text] [Related]
20. The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines.
Lau YF; Santos C; Torres-Vélez FJ; Subbarao K
J Virol; 2011 Jan; 85(1):76-85. PubMed ID: 20962087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
